Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2024 | Exploring emerging biomarkers and therapies for metaplastic breast cancer

Pooja Advani • 13 Dec 2024
SABCS 2024
Breast Cancer

Pooja Advani, MBBS, MD, Mayo Clinic, Jacksonville, FL, gives an overview of hypothesis-generating research on biomarkers and therapies for metaplastic breast cancer. While heterogeneity among subtypes like spindle cell and squamous was not explored, future work aims to define their unique features. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Pooja Advani

Molecular and immune profiling of metaplastic and invasive ductal TNBC
3:04
Molecular and immune profiling of metaplastic and invasive ductal TNBC
Pooja Advani • 13 Dec 2024

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026
The content of VJOncology is intended for healthcare professionals